Children and adolescents using an advanced hybrid closed-loop system for type 1 diabetes can tolerate an unannounced snack containing 20 g of carbohydrate without excessive blood sugar fluctuations, Italian researchers report.
06-04-2022 | ADA 2022 | Conference coverage | News
The iLet bionic pancreas closed-loop insulin delivery system provides good glucose control without the need for the user to count carbohydrates, show findings from the pivotal trial.
06-04-2022 | ADA 2022 | Conference coverage | News
The first phase 3 trial of an SGLT2 inhibitor in children and young people with type 2 diabetes shows that dapagliflozin significantly improves their glucose control – as long as they remember to take it.
The Patient Health Questionnaire-9, which screens for depressive symptoms, underestimates suicide risk in adolescents and young adults with type 1 diabetes when compared with a validated suicide-specific measure, research shows.
Young people with type 1 diabetes are at increased risk for hospitalization for acute complications at the time of transition from pediatric to adult care, say researchers.